Product NDC: | 0603-9063 |
Proprietary Name: | Cetirizine Hydrochloride |
Non Proprietary Name: | cetirizine hydrochloride |
Active Ingredient(s): | 1 mg/mL & nbsp; cetirizine hydrochloride |
Administration Route(s): | ORAL |
Dosage Form(s): | SYRUP |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 0603-9063 |
Labeler Name: | Qualitest Pharmaceuticals |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA078496 |
Marketing Category: | ANDA |
Start Marketing Date: | 20090925 |
Package NDC: | 0603-9063-58 |
Package Description: | 480 mL in 1 BOTTLE (0603-9063-58) |
NDC Code | 0603-9063-58 |
Proprietary Name | Cetirizine Hydrochloride |
Package Description | 480 mL in 1 BOTTLE (0603-9063-58) |
Product NDC | 0603-9063 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | cetirizine hydrochloride |
Dosage Form Name | SYRUP |
Route Name | ORAL |
Start Marketing Date | 20090925 |
Marketing Category Name | ANDA |
Labeler Name | Qualitest Pharmaceuticals |
Substance Name | CETIRIZINE HYDROCHLORIDE |
Strength Number | 1 |
Strength Unit | mg/mL |
Pharmaceutical Classes | Histamine H1 Receptor Antagonists [MoA],Histamine-1 Receptor Antagonist [EPC] |